nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Apelin: an antithrombotic factor that inhibits platelet function
|
Adam, Frédéric |
|
|
127 |
7 |
p. 908-920 |
artikel |
2 |
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease
|
Telen, Marilyn J. |
|
|
127 |
7 |
p. 810-819 |
artikel |
3 |
Breast cancer and thrombosis: timing matters
|
Paulus, Jessica K. |
|
|
127 |
7 |
p. 793-794 |
artikel |
4 |
CCL5 derived from platelets increases megakaryocyte proplatelet formation
|
Machlus, Kellie R. |
|
|
127 |
7 |
p. 921-926 |
artikel |
5 |
Central nervous system complications and management in sickle cell disease
|
DeBaun, Michael R. |
|
|
127 |
7 |
p. 829-838 |
artikel |
6 |
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas
|
Culjkovic-Kraljacic, Biljana |
|
|
127 |
7 |
p. 858-868 |
artikel |
7 |
Editorial Board
|
|
|
|
127 |
7 |
p. i |
artikel |
8 |
Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease
|
Hoban, Megan D. |
|
|
127 |
7 |
p. 839-848 |
artikel |
9 |
ICAM-1–expressing neutrophils exhibit enhanced effector functions in murine models of endotoxemia
|
Woodfin, Abigail |
|
|
127 |
7 |
p. 898-907 |
artikel |
10 |
Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome
|
Walker, Sarah |
|
|
127 |
7 |
p. 948-951 |
artikel |
11 |
Might haplo “be the (better) match”?
|
Kanakry, Jennifer A. |
|
|
127 |
7 |
p. 799-800 |
artikel |
12 |
Misshapen/NIK-related kinase (MINK1) is involved in platelet function, hemostasis, and thrombus formation
|
Yue, Ming |
|
|
127 |
7 |
p. 927-937 |
artikel |
13 |
Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology
|
Zhang, Dachuan |
|
|
127 |
7 |
p. 801-809 |
artikel |
14 |
Not only TKI! Targeting FLT3-ITD by autophagy
|
Marcucci, Guido |
|
|
127 |
7 |
p. 796-797 |
artikel |
15 |
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease
|
Gordeuk, Victor R. |
|
|
127 |
7 |
p. 820-828 |
artikel |
16 |
Platelet production: new players in the field
|
Pluthero, Fred G. |
|
|
127 |
7 |
p. 797-799 |
artikel |
17 |
Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells
|
Larrue, Clément |
|
|
127 |
7 |
p. 882-892 |
artikel |
18 |
Pure red cell aplasia revealing nonnodal mantle cell lymphoma
|
Durot, Eric |
|
|
127 |
7 |
p. 952 |
artikel |
19 |
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML
|
Wong, Terrence N. |
|
|
127 |
7 |
p. 893-897 |
artikel |
20 |
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
|
Kanate, Abraham S. |
|
|
127 |
7 |
p. 938-947 |
artikel |
21 |
Shooting the messenger (RNA) in B-cell lymphoma
|
Yeomans, Alison |
|
|
127 |
7 |
p. 794-796 |
artikel |
22 |
Sickle cell disease: challenges and progress
|
Parise, Leslie V. |
|
|
127 |
7 |
p. 789 |
artikel |
23 |
Singer K, Fisher B. Studies on abnormal hemoglobins, VI: electrophoretic demonstration of type S (sickle cell) hemoglobin in erythrocytes incapable of showing the sickle cell phenomenon. Blood. 1953;8(3): 270-275.
|
|
|
|
127 |
7 |
p. 791 |
artikel |
24 |
Targetable genetic features of primary testicular and primary central nervous system lymphomas
|
Chapuy, Bjoern |
|
|
127 |
7 |
p. 869-881 |
artikel |
25 |
VTE in breast cancer
|
|
|
|
127 |
7 |
p. 953 |
artikel |
26 |
When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data
|
Walker, Alex J. |
|
|
127 |
7 |
p. 849-857 |
artikel |